LabConnect Forms Strategic Advisory Board
LabConnect, a pioneering provider of central lab services and functional service provider solutions, has recently announced the establishment of its Strategic Advisory Board. This strategic initiative underscores LabConnect's commitment to expand its global presence and enhance its investments in innovation and technology. The board aims to elevate LabConnect's capability in offering efficient, transparent, and sustainable solutions to its clients and partners.
Key Members Join the Advisory Board
The newly formed Strategic Advisory Board comprises highly distinguished professionals from the pharmaceutical and clinical sectors:
Scott Evangelista
Mr. Evangelista brings over 30 years of leadership experience in the pharmaceutical industry. As the current CEO of Cairn Therapeutics, Inc., he oversees the company's strategic direction, fundraising efforts, and stakeholder relations. Scott previously served as Executive Chairman of Cairn, and has held pivotal positions as President and COO of Ironshore Pharmaceuticals and President of Integrated Health Services at IQVIA. His broad experience will be vital in steering LabConnect’s innovations and growth.
David Johnston, Ph.D.
Dr. Johnston adds significant expertise with a brilliant background in scientific operations. As the Senior Vice President and President of Clinical Research at Thermo Fisher, following the acquisition of PPD, he has been instrumental in leading global clinical development at LabCorp and PPD. His extensive knowledge in clinical operations is set to bolster LabConnect's productivity and efficiency in clinical trials.
Patrick Hastings
Mr. Hastings is renowned for his operational excellence and business development acumen within the pharmaceutical sector. Previously serving as the Global VP at Labcorp, he led the Central Laboratory Services business unit. His rich history with companies like Merck & Co., Bayer Healthcare, and Eli Lilly equips him with vital insights to enhance LabConnect's operational performance and service delivery.
Significance of the Advisory Board
CEO of LabConnect, Wes Wheeler, expressed his enthusiasm about the appointments, stating, "We are excited to welcome Scott, David, and Patrick to our Strategic Advisory Board. Their collective knowledge and leadership will be crucial as we pursue innovation and growth. This board will significantly contribute to our mission of delivering exceptional client and partner value."
The formation of this board represents an important milestone for LabConnect as it continues to solidify its international leadership position in the laboratory services industry. The advisory team’s insights and recommendations will aid in navigating the complexities of the biotechnology landscape.
LabConnect's Commitment to Innovation
LabConnect has always been committed to fostering healthier communities by aiding clients in the development of groundbreaking medications for patients worldwide. This is reflected in the strategic direction the company is taking with the establishment of its Advisory Board, as it aims to reinforce its core values while adapting to the ever-evolving industry demands.
About LabConnect
LabConnect is a premier provider of Central Laboratory Services, specialized scientific consulting, and innovative data integration for complex studies, including immuno-oncology and gene therapies. The combination of cutting-edge technology and specialized expertise enables LabConnect to offer comprehensive laboratory services to drug development companies, ensuring they meet all their testing needs effectively and efficiently.
Frequently Asked Questions
What is the Strategic Advisory Board's purpose at LabConnect?
The board aims to enhance LabConnect's strategic direction and foster innovation through the insights of its experienced members.
Who are the members of the Strategic Advisory Board?
The board includes Scott Evangelista, David Johnston, Ph.D., and Patrick Hastings, all seasoned professionals in the pharmaceutical sector.
How will the Advisory Board impact LabConnect's operations?
The board will provide valuable guidance to improve efficiency, transparency, and overall service delivery in LabConnect's operations.
What services does LabConnect offer?
LabConnect specializes in providing Central Laboratory Services, scientific consulting, and comprehensive data integration for complex clinical studies.
What is LabConnect's mission?
LabConnect's mission is to facilitate the development of new medicines while supporting healthier communities globally.
